Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01662778Phase 4Completed
Phase 4, randomised, single-blind trial of fluticasone propionate in asthma (4 arms), sponsored by Imperial College London. Primary endpoint: Adenosine Monophosphate Challenge Test PC20 at 2 hours. Started Dec 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01662778.